Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/karger/biological-changes-in-serum-antiproteases-as-related-to-tumor-rXlq85vaZe
References
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
- Publisher
- Karger
- Copyright
- © 1988 S. Karger AG, Basel
- ISSN
- 1010-4283
- eISSN
- 1423-0380
- DOI
- 10.1159/000217541
- Publisher site
- See Article on Publisher Site
Abstract
The two major antiproteases (alpha-1-antitrypsin and alpha-2-macroglobulin) were studied in the serum of cancer patients (273 and 103 subjects, respectively) and in a control group. In cancer patients, the values were stratified by clinical stage (local, loco-regional and metastatic disease). Serum alpha-1-antitrypsin was different in normal people (341 ± 110.7 mg/dl) than in every cancer group (p < 0.0005). The behavior of alpha-2-macroglobulin was similar, with significant differences (p < 0.0005) between normal people (317.6 ± 105.4 mg/dl) and the cancer groups. Serum alpha-1-antitrypsin was different in local, loco-regional and metastatic disease; however, alpha-2-macroglobulin did not show these differences. In metastatic disease, sensitivity was 96.66% for alpha-1-antitrypsin and 94.79% for alpha-2-macroglobulin.
Journal
Tumor Biology – Karger
Published: Jan 1, 1988
Keywords: Cancer patients; Stage; α 1 -Antitrypsin; α 2 -Macroglobulin; Antiproteases